WO1999066321A3 - Proteines de reconnaissance des formes - Google Patents

Proteines de reconnaissance des formes Download PDF

Info

Publication number
WO1999066321A3
WO1999066321A3 PCT/CA1999/000544 CA9900544W WO9966321A3 WO 1999066321 A3 WO1999066321 A3 WO 1999066321A3 CA 9900544 W CA9900544 W CA 9900544W WO 9966321 A3 WO9966321 A3 WO 9966321A3
Authority
WO
WIPO (PCT)
Prior art keywords
pattern recognition
animal species
measure
resistance against
against bacteria
Prior art date
Application number
PCT/CA1999/000544
Other languages
English (en)
Other versions
WO1999066321A2 (fr
Inventor
M Anthony Hayes
Wineeta Weebadda
Gordon J Hoover
Original Assignee
Univ Guelph
M Anthony Hayes
Wineeta Weebadda
Gordon J Hoover
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Guelph, M Anthony Hayes, Wineeta Weebadda, Gordon J Hoover filed Critical Univ Guelph
Priority to AU41277/99A priority Critical patent/AU4127799A/en
Priority to CA002334905A priority patent/CA2334905A1/fr
Publication of WO1999066321A2 publication Critical patent/WO1999066321A2/fr
Publication of WO1999066321A3 publication Critical patent/WO1999066321A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4724—Lectins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

L'invention concerne de nouvelles protéines de reconnaissance des formes. Les protéines de reconnaissance des formes constituent des marqueurs utiles d'une résistance naturelle aux infections bactériennes.
PCT/CA1999/000544 1998-06-12 1999-06-11 Proteines de reconnaissance des formes WO1999066321A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU41277/99A AU4127799A (en) 1998-06-12 1999-06-11 Pattern recognition proteins
CA002334905A CA2334905A1 (fr) 1998-06-12 1999-06-11 Proteines de reconnaissance des formes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8937098P 1998-06-12 1998-06-12
US60/089,370 1998-06-12

Publications (2)

Publication Number Publication Date
WO1999066321A2 WO1999066321A2 (fr) 1999-12-23
WO1999066321A3 true WO1999066321A3 (fr) 2000-06-29

Family

ID=22217297

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1999/000544 WO1999066321A2 (fr) 1998-06-12 1999-06-11 Proteines de reconnaissance des formes

Country Status (3)

Country Link
AU (1) AU4127799A (fr)
CA (1) CA2334905A1 (fr)
WO (1) WO1999066321A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861731B1 (fr) * 2003-10-30 2006-02-24 Centre Nat Rech Scient Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
CN113880932B (zh) * 2021-09-27 2023-12-12 北京市水产科学研究所（国家淡水渔业工程技术研究中心） 锦鲤Ladderlectin蛋白或其编码基因在调控锦鲤抗病原菌感染中的应用

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE 1 January 1900 (1900-01-01), XP002127553, Database accession no. 1999004084 *
G J HOOVER ET AL.: "Lipopolysaccharide-binding lectins and pentraxins in plasma of salmonids genetically resistant to Aeromonas Salmonicida", FASEB JOURNAL, vol. 12, no. 5, 20 March 1998 (1998-03-20), BETHESDA, MD US, pages A807, abstract 4678, XP002127550 *
G J HOOVER ET AL.: "Plasma proteins if rainbow trout (Oncorhynchus mykiss) isolated by binding to lipopolysaccharide from Aeromonas salmonicida", COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY. B. COMPARATIVE BIOCHEMISTRY., vol. 120, no. 3, July 1998 (1998-07-01), PERGAMON PRESS, LONDON., GB, pages 559 - 569, ISSN: 0305-0491 *
J DELAY ET AL.: "Focal depletion of pulmonary ficolin in bacterial pneumonia in pigs", FASEB JOURNAL., vol. 13, no. 5, 15 March 1999 (1999-03-15), FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD., US, pages A829, abstract 639.6, XP002127552, ISSN: 0892-6638 *
J DELAY ET AL.: "Porcine ficolins are lectins for lipopolysaccharides of Actinobacillus suis and A. pleuropneumoniae", FASEB JOURNAL, vol. 12, no. 5, 20 March 1998 (1998-03-20), BETHESDA, MD US, pages A807, abstract 4676, XP002127549 *
U HOLMSKOV ET AL.: "The plasma levels of conglutinin are heritable in cattle and low leveles predispose to infection", IMMUNOLOGY, vol. 93, March 1998 (1998-03-01), OXFORD, GB, pages 431 - 436, XP002127551, ISSN: 0019-2805 *
W K C WEEBADDA ET AL.: "A novel protein isolated from the avian respiratory tract fluids by calcium-dependent affinity to rhamnan-rich oligosacharide of pathogenic E. coli", FASEB JOURNAL, vol. 13, no. 5, 15 March 1999 (1999-03-15), BETHESDA, MD US, pages a829, abstract 639.5, XP000857953 *

Also Published As

Publication number Publication date
AU4127799A (en) 2000-01-05
WO1999066321A2 (fr) 1999-12-23
CA2334905A1 (fr) 1999-12-23

Similar Documents

Publication Publication Date Title
PT754050E (pt) Metodos e materiais contra bacterias gram-positivas
ATE347277T1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
DE69724713D1 (de) System zur Identifizierung eines tierischen Körpers
AU2003212265A1 (en) Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
ID18254A (id) Pemicu yang dapat diinduksi oleh garam yang dapat diturunkan dari bakteri asam laktat, dan penggunaannya dalam bakteri asam laktat untuk produksi protein yang diinginkan
DZ3167A1 (fr) Combinaison de bactéries d'acide lactique et son utilisation pour prevenir et/ou traiter les infections et les états inflammatoires.
MY131300A (en) Antibacterial agents
WO2001092309A3 (fr) Defensine humaine beta 3 (hbd-3), peptide antimicrobien hautement cationique de la defensine beta
IN167562B (fr)
ATE347611T1 (de) Automatischer apparat zum messen von wassertoxizität
ATE466585T1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
EP1728866A3 (fr) Cassettes d'expression de luciferase et méthodes d'utlisation
DE69202114D1 (de) Behandlungsverfahren für Werkstoffe aus Eisen zur gleichzeitigen Verbesserung ihrer Korrosionsfestigkeit und ihrer Verschleisseigenschaften.
EP1019084A4 (fr) Nouveau polypeptide antimicrobien et procedes d'utilisation
WO2001010901A3 (fr) Compositions antimicrobiennes comprenant l'histone h1, trousses, et modes d'emploi desdites compositions
DE69232483D1 (de) Mycobacteriumprotein und dessen verwendung
ATE362765T1 (de) Milchsäurebakterien mit anxiolytischer wirkung, und ihre verwendungen
WO1999066321A3 (fr) Proteines de reconnaissance des formes
MXPA03003095A (es) Emulsion comestible que comprende microorganismos vivos y aderezos o salsas de guarnicion que comprenden la misma.
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
WO2001089997A3 (fr) Moyen de traitement de l'eau
WO2005021575A3 (fr) Molecules de signalisation bacterienne regulant en les diminuant les proprietes de virulence pathogene bacterienne
WO1999012552A8 (fr) 9a-AZALIDES UTILISES COMME AGENTS ANTIMICROBIENS VETERINAIRES
DE69923559D1 (de) Methoden zur inhibierung von helicobacter pylori

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2334905

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09719156

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA